Catalog item
Request a quoteOXYCODONE AND ACETAMINOPHEN CAPS
6505FSC
01NCB code
210-4450Item number
NIIN 01-210-4450
- DEMIL code
- A
Identification
- Item name code
- 48975
- PINC
- 0048975
- Criticality code
- X
- II
- 0
- DEMIL code
- A
- DEMIL integrity code
- 1
- NIIN assigned
- 12-JUN-85
- Precious metals indicator
- A
- Hazardous material indicator
- Y
- Hazardous characteristics code
- N1
Freight
- ACTY CD
- 54
Related items
Standardization
- NIIN status code
- 4
History
Identification changes
- Item name code
- 48975
- DEMIL code
- A
- Criticality code
- X
- Precious metals indicator
- A
- Cancelled date
- 22-JUL-2026
- NIIN status code
- 4
Past part numbers
| Part number | CAGE | RNCC | RNVC |
|---|---|---|---|
| NDC00406-0532-01 | 00CT0 MALLINCKRODT, INC. DBA COVIDIEN DIV MALLINCKRODT | 3 | 2 |
| NDC00045-0526-60 | 04501 MCNEIL LAB INC MCNEIL PHARMACEUTICAL DIV | 3 | 2 |
| NDC00045-0526-60 | 04501 MCNEIL LAB INC MCNEIL PHARMACEUTICAL DIV | 5 | 9 |
| TYLOX CAPSULES | 04501 MCNEIL LAB INC MCNEIL PHARMACEUTICAL DIV | 5 | 1 |
| TYLOX CAPSULES | 04501 MCNEIL LAB INC MCNEIL PHARMACEUTICAL DIV | 5 | 9 |
| NDC00603-4997-21 | 0ET99 GENERICS BIDCO I, LLC DBA PAR PHARMACEUTICAL | 5 | 2 |
| NDC00603-4997-21 | 0ET99 GENERICS BIDCO I, LLC DBA PAR PHARMACEUTICAL | 3 | 2 |
| NDC00054-2795-25 | 1H5R4 ROXANE LABORATORIES, INC. DIV SUB OF BOEHRINGER INGELHEIM CORP. | 3 | 2 |
| NDC00054-2796-25 | 1H5R4 ROXANE LABORATORIES, INC. DIV SUB OF BOEHRINGER INGELHEIM CORP. | 5 | 2 |
| NDC00054-2796-25 | 1H5R4 ROXANE LABORATORIES, INC. DIV SUB OF BOEHRINGER INGELHEIM CORP. | 3 | 2 |
| NDC00406-0532-01 | 1SJ92 MALLINCKRODT LLC DIV DOSAGE PHARMACEUTICAL | 3 | 2 |
| NDC50458-0526-60 | 59484 JANSSEN PHARMACEUTICA INC | 3 | 2 |
| NDC50458-0526-60 | 5AJ94 JANSSEN PHARMACEUTICALS, INC. | 3 | 2 |
| NDC00045-0526-60 | 79717 JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC. | 3 | 2 |
| TYLOX CAPSULES | 79717 JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC. | 5 | 1 |
Request a quote
Your request goes to A-DEFENSE, a US Defense supplier in Texas, who will reply by email.